IC-OS Weekly Webinar - Cardio-Oncology and Valve Disease: What are the Best Cardiac Imaging Practices?
Details
Organised by
Date
- America/New_York
Chadi Ayoub
Chadi Ayoub is a Cardiologist at Mayo Clinic, Rochester, USA
Read MoreChadi Ayoub is a Cardiologist at Mayo Clinic, Rochester, USA
Show LessEric Yang
Dr. Eric Yang currently serves as an Associate Clinical Professor of Medicine at the University...
Read MoreDr. Eric Yang currently serves as an Associate Clinical Professor of Medicine at the University of California at Los Angeles, where he has served as clinical faculty since 2011. He obtained his medical degree at the University of Illinois at Chicago College of Medicine, and underwent residency and fellowship training at Harbor-UCLA Medical Center, where he also served as chief fellow. Dr. Yang is the Founder and Director of the UCLA Cardio-oncology Program which was formally established in 2016. The mission of this program is to provide high quality, multidisciplinary clinical cardiovascular care to the cancer population of UCLA Health to patients either at risk for, or who have developed short and long-term cardiotoxicity from both historical and modern cancer therapies. In 2022, the UCLA Cardio-Oncology Program was designated an International Cardio-Oncology Society Center of Excellence, Gold Tier, in its inaugural selection process. Dr. Yang’s research interests are focused on the mechanistic cross talk of how the biological effects of cancer and/or cancer treatment-associated cardiotoxicity may yield insights into the development of traditional cardiovascular disease, including atherosclerotic disease, heart failure, arrhythmias, and hypertension. He is also focusing on exploring effective diagnostic and pharmacologic treatment strategies as an investigator in both national and international based registries of immune checkpoint associated myocarditis and chimeric antigen T-cell receptor therapy related cardiotoxicity. He is also active in evaluating both short- and long-term cardiovascular effects of treatments in cancer survivors, including those with autonomic dysfunction and those who have received high risk chemoradiation treatments. Dr. Yang has served on National Cardio-oncology Committees within the American College of Cardiology and the American Heart Association. He also is involved with the National Comprehensive Cancer Network Survivorship Panel and serves on the inaugural editorial board of JACC: Cardio-Oncology, one of the first major cardiology journals dedicated to the science of Cardio-Oncology. Since joining UCLA, Dr. Yang has also been heavily involved in medical education, where he serves as Associate Program Director of the UCLA-Olive View-West LA VA Cardiovascular Diseases Fellowship. He is also a team member of the structural heart program, where he is involved with cardiovascular imaging of the team’s interventional percutaneous procedures (ie TAVR, Mitraclip, etc). His clinical interests include cardio-oncology, cardiac imaging, medical education, valvular disease, and hemodynamics.
Show LessJoseph Carver
Joseph R. Carver, MD, FACC is a Board Certified cardiologist. He is the Founding Editor of the...
Read MoreJoseph R. Carver, MD, FACC is a Board Certified cardiologist. He is the Founding Editor of the American Journal of Managed Care and was a Senior Corporate Medical Director at Aetna U.S. Healthcare from 1992-2001 where he was responsible for new program development and directed the National Medical Excellence Program. From 1999-2001, he was Co-chairperson of the New Jersey and Michigan Working Groups that established voluntary agreements among the insurers in those states to cover the routine costs of clinical trial participation for cancer patients. He is one of the Founding Editors of Cardio-oncology Journal. He currently is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center. He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of Cardio-oncology. He was the recipient of the IS Ravdin Master Clinician Award at Penn in 2012 and is one of the founding members of Penn Medicine’s Academy of Master Clinicians. He received the Thomas Force Award in 2020.
Show LessKalliopi Keramida
A cardiologist at Medical School, University of Cyprus. Features in 1 video on Wondr Medical....
Read MoreA cardiologist at Medical School, University of Cyprus. Features in 1 video on Wondr Medical. Kalliopi Keramida generally speaks on Cardio-Oncology, Cardiovascular Disease in the Elderly, Cardio-Oncology, and Oncology Imaging.
Show LessSusan Strong
A patient advocate. Features in 1 video on Wondr Medical. Susan Strong generally speaks on...
Read MoreA patient advocate. Features in 1 video on Wondr Medical. Susan Strong generally speaks on Cardio-Oncology, Cardiovascular Disease in the Elderly, Cardio-Oncology, and Oncology Imaging.
Show Less